Mercy BioAnalytics is a pre-commercial diagnostics company on a mission to save lives and relieve suffering through the early detection of cancer. We are developing ,broadly accessible, inexpensive, blood-based screening tests, initially focused on two critical areas of unmet need: detection of lung and ovarian cancer in patients who are at higher risk. At Mercy, we believe all those at higher risk for developing cancer should have access to high performing, affordable screening tests, and are committed to advancing our innovative portfolio of tests towards global clinical impact.